|Akers Biosciences, Inc
||COM SHS NPV
||EPS - Basic
||Market Cap (m)
|Health Care Equipment & Services
Akers Biosciences Share Discussion Threads
Showing 3751 to 3768 of 3775 messages
|Must be still collecting the issue money; Does not feel right|
|Lots of words, vaguely pertaining to the (endlessly repeated) point that you don't like Dr Akers.Beyond that, as a previous poster suggested, nothing of much use.|
|Nobody throws good money after bad
unless they were great stock pickers like Neil Woodford who is looking to recruit; With a closing date last Thursday, I suppose they are cutting the application due to massive over subscription and attention to the-inauguration balls invitations on offer to The Akers|
|"a constructive comment" (or at least something pertaining to knowledge of the company)Qaz - It was interesting to note in the last conference call that the breakeven level of sales had fallen from circa $7m to $4.6m pa, which implies cash burn has dropped from circa $80k pw to closer to $35k. This implies the newly raised cash may give them a 12-18 month window. Over that time it is possible they get traction on the wellness side - the market would, I suspect, richly reward even marginal success on this front, given a market cap of sub $10m.I'm disappointed management did not participate in the cash raise. It doesn't make a great deal of sense - even a token level of participation would have had an amplified impact on confidence. Perhaps they were limited for some reason or perhaps they intend purchasing in the after market. I think breath actuated tests are still a great idea - particularly when targeting a wellness market populated by health enthusiasts. With some medtechs the risk is getting the products to market - here, the risks are clearly related to trust. But nonetheless, if it works out from this valuation level and the risks are ameliorated, investors will be very well rewarded, imo dyor.|
|There is plenty of life in me; sadly you can't say the same about Walter's outfit. Just sucking money|
|Cheer up Norbus,there's life in you yet.|
|"These could half again in a week".
And you could make a constructive comment in a week. Strange things do sometimes happen.....|
|Not silk purse from a sow's ear ; today is the deadline to close. I hope for all holders sake that the $1.20 pricing is from greed and not despair. These could half again in a week|
|Duck or no dinner.|
|something not right whichever way you look at it.
Someone stealing a chunk cheap,
or curtains being measured|
|The initial S3 form included the comment: "...and a per share price of $3.30 based on the closing sale price of our common stock on October 18, 2016". The price of $1.20 with warrants at $1.50 suggests to me either gross incompetence or, as you say Norbus, no confidence in the company and the management. Or perhaps both.|
|$1.2 for $2000000 !
I doubt this is careful housekeeping and most likely the market had enough; Even money they will
not make it; I say that, because if revenues were on doorstep from China,they can underwrite them
and at much higher than $1.20; I also think this money is coming from insider back pockets.
I over rated the CEO on his past M&A record. I think he is past his sell by date|
Looking for the RNS I could not find on their website, I see so many people around the company; board management etc.. You'd think they are running a big company|
I reckon they are seriously stuck for some real news before they put their hands out to siphon more money into the benefits pot. Critical Junction if China does not come through|
Still no new SEC filings for AKERs: hTtp://www.nasdaq.com/symbol/aker/sec-filings|
|Happy New year to all Akers Biosciences Holders: May 2017 be Merry and Bright for us all.|